Thiamidol shows rapid, sustained benefit for facial hyperpigmentation
We’re highlighting a December 2025 article that we’re sure you’ll want to dive into! A 90‑patient randomized study found that thiamidol formulations produced noticeable improvement in facial hyperpigmentation fast: objective colorimeter measures (L* and ITA°) and clinician‑assessed radiance rose as early as week 2 and continued through 12 weeks with durability during a 6‑week regression phase. Both a twice‑daily serum and a multi‑product regimen (SPF day lotion + serum; night cream + serum) were effective, with the full regimen trending toward greater radiance than serum alone. The findings support thiamidol as a practical, evidence‑based topical option for melasma, post‑inflammatory hyperpigmentation and lentigines, when combined with strict photoprotection.
Read the full article for formulation details, treatment schedules and patient selection criteria before adding thiamidol into your clinic toolbox.
J Drugs Dermatol. 2025;24(12):1195-1202. doi:10.36849/JDD.9517
Blog write-up assisted by AI
